FORM
6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
For
the
month of June 2007
Commission
File Number: 001-15152
SYNGENTA
AG
(Translation
of registrant’s name into English)
Schwarzwaldallee
215
4058
Basel
Switzerland
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F:
|
Form
20-F
|
X
|
Form
40-F
|
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):
|
Yes
|
No
|
X
|
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):
|
Yes
|
No
|
X
|
Indicate
by check mark whether by furnishing the information contained in this Form,
the
Registrant is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
|
Yes
|
No
|
X
|
If
“Yes”
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): N/A
| Re: | SYNGENTA AG |
| Press Release: |
“Syngenta
agrees agriculture biotechnology research collaboration in
China”
|
Filed
herewith is a press release related to Syngenta AG. The full text of the
press
release follows:
#
#
#
Item
1
| Syngenta International AG | ||
| Media Office | ||
| CH-4002 Basel | ||
| Switzerland | ||
| Telephone: | +41 61 323 23 23 | |
| Fax: | +41 61 323 24 24 | |
| www.syngenta.com | ||
| Media Release |
Syngenta
agrees agriculture biotechnology research collaboration in
China
Basel,
Switzerland/ Beijing, PRC, June 25, 2007
Syngenta
announced
today that it has agreed a five-year research collaboration with the
Institute
of Genetics and Developmental Biology (IGDB) in Beijing, China. The agreement
focuses on the identification and development of novel agronomic traits
including drought tolerance for key crops, including corn, soybean, wheat,
sugar
beet and sugar cane. IGDB forms part of the Chinese Academy of Sciences
in
Beijing and is one of China’s leading biotechnology research
institutes.
Syngenta
will have
rights to commercialize previously and newly developed traits in the
agreed
range of field crops. Under the agreement, traits will not only be developed
for
the Chinese seeds market, but also for global agriculture markets. Financial
details of the agreement have not been disclosed.
“We
are extremely
pleased to have IGDB as one of our research partners”, said Dr. David Lawrence,
Head of Research and Development at Syngenta. “The Institute has profound
discovery research in genetics, developmental biology and agricultural
sciences.
Its science base fits very well with Syngenta’s commitment to meet the high
demand from farmers both inside and outside of China for new seed products.
Combining our technology platforms will increase the speed of introduction
of
new and improved seed varieties.”
“The
collaboration
with Syngenta gives our Institute access to global agriculture markets
through
integration of new traits in the Syngenta seeds portfolio. This is an
important
step in our ambition to extend our research programs beyond China,” said Dr.
Yongbiao Xue, Director at IGDB.
Syngenta
and IGDB
will commence their collaboration project with immediate effect.
Syngenta
is a
world-leading agribusiness committed to sustainable agriculture through
innovative research and technology. The company is a leader in crop
protection, and ranks third in the high-value commercial seeds
market. Sales in 2006 were approximately $8.1
billion. Syngenta employs around 19,500 people in over
90 countries. Syngenta is listed on the Swiss stock exchange
(SYNN) and in New York (SYT). Further information is available at
www.syngenta.com.
Syngenta
–
June
25,
2007 / Page 1 of 2
|
Media
Enquiries:
|
Médard
Schoenmaeckers (Switzerland)
|
+41
61 323
2323
|
|
Sarah
Hull
(US)
|
+1
202 628
2372
|
|
|
Analysts/Investors:
|
Jonathan
Seabrook
|
+41
61 323
7502
|
|
+1
202 737
6520
|
||
|
Jennifer
Gough
|
+41
61 323
5059
|
|
|
+1
202 737
6521
|
This
document
contains forward-looking statements, which can be identified by terminology
such
as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’,
‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to
risks and uncertainties that could cause the actual results to differ
materially
from these statements. We refer you to Syngenta's publicly available
filings
with the U.S. Securities and Exchange Commission for information about
these and other risks and uncertainties. Syngenta assumes no obligation
to
update forward-looking statements to reflect actual results, changed
assumptions
or other factors. This document does not constitute, or form part of,
any offer
or invitation to sell or issue, or any solicitation of any offer, to
purchase or
subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor
shall it
form the basis of, or be relied on in connection with, any contract
therefor.
Syngenta
– June 25, 2007 / Page 2 of 2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| SYNGENTA AG | |||
| |
|
|
|
| Date: June 25, 2007 | By: | /s/ Christoph Mäder | |
|
|
|||
| Name: | Christoph Mäder | ||
|
Title:
|
Head Legal & Taxes | ||